Dr. Sharba Tasneem

Employment

Employment history is unavailable.

Education

• Jamia Hamdard PHD
  2016 - 2022
• Jamia Hamdard Faculty of Pharmacy

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling
  Bioorganic Chemistry 2024 DOI: 10.1016/j.bioorg.2024.107336
  +Save
• Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancer
  Future Medicinal Chemistry 2023 DOI: 10.4155/fmc-2023-0105
  +Save
• Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent
  Bioorganic Chemistry 2023 DOI: 10.1016/j.bioorg.2023.106449
  +Save
• A TEXT BOOK OF HOSPITAL AND CLINICAL PHARMACY
  BOOKERA PUBLISHER AND DISTRIBUTOR 2023
  +Save
• Synthesis, biological evaluation and docking studies of methylene bearing cyanopyrimidine derivatives possessing a hydrazone moiety as potent Lysine specific demethylase-1 (LSD1) inhibitors: A promising anticancer agents
  Bioorganic Chemistry 2022 DOI: 10.1016/j.bioorg.2022.105885
  +Save
• Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics
  Mini-Reviews in Medicinal Chemistry 2022 DOI: 10.2174/1389557519666211221144013
  +Save
• Green recipes to quinoline: A review
  European Journal of Medicinal Chemistry 2019 DOI: 10.1016/j.ejmech.2018.11.026
  +Save
• Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents
  European Journal of Medicinal Chemistry 2015 DOI: 10.1016/j.ejmech.2015.07.026
  +Save
• EGFR INHIBITORS: ROLE IN CANCER THERAPY
  +Save